Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 370

1.

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.

Marascio J, Spratt DE, Zhang J, Trabulsi EJ, Le T, Sedzorme WS, Beeler WH, Davicioni E, Dabbas B, Lin DW, Gore JL, Bloom M, Mann M, Mark JR, Calvaresi A, Godwin JL, McCue P, Hurwitz MD, Kelly WK, Lallas CD, Knudsen KE, Gomella LG, Dicker AP, Den RB.

Prostate Cancer Prostatic Dis. 2019 Nov 12. doi: 10.1038/s41391-019-0185-7. [Epub ahead of print]

PMID:
31719663
2.

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.

Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Fleshner NE, Tilki D, Chandrasekar T.

Urology. 2019 Nov 6. pii: S0090-4295(19)30949-5. doi: 10.1016/j.urology.2019.10.012. [Epub ahead of print]

PMID:
31705947
3.

Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario.

Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Fleshner NE, Lallas CD, Trabulsi EJ, Chandrasekar T.

Ther Adv Urol. 2019 Oct 13;11:1756287219882809. doi: 10.1177/1756287219882809. eCollection 2019 Jan-Dec.

4.

Should Urologists Ask Their Adult Patients If They Were Premature?

Gomella LG.

Can J Urol. 2019 Oct;26(5):9905. No abstract available.

6.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM.

Radiother Oncol. 2019 Dec;141:137-143. doi: 10.1016/j.radonc.2019.08.020. Epub 2019 Sep 17.

PMID:
31540746
7.

Viral Therapy for Bladder Cancer: Everything Old is New Again.

Gomella LG.

Can J Urol. 2019 Aug;26(4):9802. No abstract available.

8.

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.

Lu-Yao G, Nikita N, Keith SW, Nightingale G, Gandhi K, Hegarty SE, Rebbeck TR, Chapman A, Kantoff PW, Cullen J, Gomella L, Kelly WK.

Eur Urol. 2019 Aug 2. pii: S0302-2838(19)30585-8. doi: 10.1016/j.eururo.2019.07.031. [Epub ahead of print]

PMID:
31420248
9.

Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation.

Trabulsi EJ, Calio BP, Kamel SI, Gomella LG, Forsberg F, McCue P, Halpern EJ.

Urology. 2019 Nov;133:187-191. doi: 10.1016/j.urology.2019.07.026. Epub 2019 Aug 1.

PMID:
31377256
10.

Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.

Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN.

Eur Urol Oncol. 2019 Jul 2. pii: S2588-9311(19)30085-9. doi: 10.1016/j.euo.2019.06.010. [Epub ahead of print]

PMID:
31278035
11.

Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.

Dylgjeri E, McNair C, Goodwin JF, Raymon HK, McCue PA, Shafi AA, Leiby BE, de Leeuw R, Kothari V, McCann JJ, Mandigo AC, Chand SN, Schiewer MJ, Brand LJ, Vasilevskaya I, Gordon N, Laufer TS, Gomella LG, Lallas CD, Trabulsi EJ, Feng FY, Filvaroff EH, Hege K, Rathkopf D, Knudsen KE.

Clin Cancer Res. 2019 Sep 15;25(18):5623-5637. doi: 10.1158/1078-0432.CCR-18-2207. Epub 2019 Jul 2.

PMID:
31266833
12.

Evolution of the Liquid Biopsy in Metastatic Prostate Cancer.

Moreno JG, Gomella LG.

Urology. 2019 Oct;132:1-9. doi: 10.1016/j.urology.2019.06.006. Epub 2019 Jun 14. Review.

PMID:
31207303
13.

Impact of Tumor Regional Involvement on Active Surveillance Outcomes: Validation of the Cumulative Cancer Location Metric in a US Population.

Leong JY, Capella C, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Chandrasekar T.

Eur Urol Focus. 2019 May 18. pii: S2405-4569(19)30136-1. doi: 10.1016/j.euf.2019.05.001. [Epub ahead of print]

PMID:
31109856
14.

Overlapping surgeries: defining the 'critical portions' of the procedure.

Leong JY, Calio B, Shah M, Sullivan P, Trabulsi EJ, Gomella LG, Lallas CD.

Can J Urol. 2019 Apr;26(2):9694-9698.

15.

Is BCG a Hazardous Drug? Ask NIOSH, OSHA, and the USP.

Gomella LG.

Can J Urol. 2019 Apr;26(2):9687-9689. No abstract available.

16.

Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.

Giri VN, Hyatt C, Gomella LG.

J Clin Oncol. 2019 Jun 10;37(17):1455-1459. doi: 10.1200/JCO.18.02181. Epub 2019 Apr 12. No abstract available.

PMID:
30978156
17.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM.

J Clin Oncol. 2019 May 10;37(14):1159-1168. doi: 10.1200/JCO.18.02158. Epub 2019 Mar 12.

PMID:
30860948
18.

Before Ordering a Genetic Test Get to Know GINA.

Gomella LG.

Can J Urol. 2018 Dec;25(6):9569. No abstract available.

19.

Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.

Shafi AA, Schiewer MJ, de Leeuw R, Dylgjeri E, McCue PA, Shah N, Gomella LG, Lallas CD, Trabulsi EJ, Centenera MM, Hickey TE, Butler LM, Raj G, Tilley WD, Cukierman E, Knudsen KE.

Eur Urol Oncol. 2018 Sep;1(4):325-337. doi: 10.1016/j.euo.2018.04.019. Epub 2018 Jun 6.

20.

PARP-1 regulates DNA repair factor availability.

Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE.

EMBO Mol Med. 2018 Dec;10(12). pii: e8816. doi: 10.15252/emmm.201708816.

Supplemental Content

Loading ...
Support Center